{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:16:57Z","timestamp":1788283017223,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajo.2026.06.031","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:45:51Z","timestamp":1782143151000},"page":"224-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association Between Statin Use and Dry Eye Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7889-4177","authenticated-orcid":false,"given":"David","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mihalache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed K.","family":"Alsarhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan K.","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Teichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-5968","authenticated-orcid":false,"given":"Marko M.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2026.06.031_bib0001","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2026.06.031_bib0002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S5555","article-title":"Etiology, prevalence, and treatment of dry eye disease","volume":"3","author":"Gayton","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.031_bib0003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0974-620X.83653","article-title":"A review on recent advances in dry eye: pathogenesis and management","volume":"4","author":"Bhavsar","year":"2011","journal-title":"Oman J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.031_bib0004","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/opo.12888","article-title":"The global prevalence of dry eye disease: a Bayesian view","volume":"41","author":"Papas","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.031_bib0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","article-title":"Impact of dry eye syndrome on vision-related quality of life","volume":"143","author":"Miljanovi\u0107","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.031_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact on quality of life and vision","volume":"1","author":"Uchino","year":"2013","journal-title":"Curr Ophthalmol Rep"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.031_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.01.004","article-title":"Modifiable lifestyle risk factors for dry eye disease","volume":"44","author":"Wang","year":"2021","journal-title":"Contact Lens Anterior Eye"},{"issue":"9","key":"10.1016\/j.ajo.2026.06.031_bib0008","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/medicina60091458","article-title":"Epidemiology and risk factors of dry eye disease: considerations for clinical management","volume":"60","author":"Britten-Jones","year":"2024","journal-title":"Medicina (Mex)"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.031_bib0009","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1081-1206(10)61413-5","article-title":"An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride","volume":"93","author":"Ousler","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.031_bib0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force Recommendation Statement","volume":"328","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ajo.2026.06.031_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061350","article-title":"Global, regional and national trends in statin utilisation in high-income and low\/middle-income countries, 2015\u20132020","volume":"12","author":"Guadamuz","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.031_bib0012","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.031_bib0013","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00417-019-04247-9","article-title":"HMG-CoA reductase expression in human eyelid tissue and in a human meibomian gland epithelial cell line","volume":"257","author":"Ooi","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.031_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.820119","article-title":"Statin use is associated with a lower risk of blepharitis: a population-based study","volume":"9","author":"Feng","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.ajo.2026.06.031_bib0015","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2026.06.031_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"key":"10.1016\/j.ajo.2026.06.031_bib0017","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2026.06.031_bib0018","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2020","journal-title":"Res Synth Methods"},{"issue":"7650","key":"10.1016\/j.ajo.2026.06.031_bib0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.ajo.2026.06.031_bib0020","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2026.06.031_bib0021","series-title":"Modelling Survival Data in Medical Research","author":"Collett","year":"2023"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.031_bib0022","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archpediatrics.2009.31","article-title":"The relative merits of risk ratios and odds ratios","volume":"163","author":"Cummings","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ajo.2026.06.031_bib0023","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jclinepi.2019.08.012","article-title":"Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest","volume":"117","author":"Foroutan","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajo.2026.06.031_sbref0024","series-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5","article-title":"Chapter 10: Analysing data and undertaking meta-analyses","author":"Deeks","year":"2024"},{"key":"10.1016\/j.ajo.2026.06.031_bib0025","series-title":"R: A Language and Environment for Statistical Computing","year":"2025"},{"key":"10.1016\/j.ajo.2026.06.031_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.ajo.2026.06.031_bib0027","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2020.05.007","article-title":"Association of dry eye disease with dyslipidemia and statin use","volume":"218","author":"Aldaas","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.031_bib0028","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/aos.15656","article-title":"Association of lipid-lowering agent use and dry eye disease: a nationwide matched case\u2013control study in Taiwan, 2002\u20132016","volume":"101","author":"Chien","year":"2023","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.031_bib0029","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/ceo.13388","article-title":"Association of dyslipidaemia and oral statin use, and dry eye disease symptoms in the blue mountains eye study","volume":"47","author":"Ooi","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.031_bib0030","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70039","article-title":"Association between statin use and dry eye disease in patients with hyperlipidemia: a population-based retrospective cohort study","volume":"17","author":"Wang","year":"2024","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ajo.2026.06.031_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2021.06.009","article-title":"Medication use and dry eye symptoms: a large, hypothesis-free, population-based study in the Netherlands","volume":"22","author":"Wolpert","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2026.06.031_bib0032","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ajo.2020.06.029","article-title":"Effect of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors on the meibomian gland morphology in patients with dyslipidemia","volume":"219","author":"Wu","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.031_bib0033","series-title":"ISPE Annual Meeting Abstracts","first-page":"112","article-title":"Association of statin use with dry eye disease","volume":"30","author":"Yu","year":"2021"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.031_bib0034","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/biom13020262","article-title":"Impact of tumor necrosis factor receptor 1 (TNFR1) polymorphism on dry eye disease","volume":"13","author":"Acuna","year":"2023","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.ajo.2026.06.031_bib0035","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jclinepi.2005.01.006","article-title":"In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias","volume":"58","author":"Terrin","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajo.2026.06.031_bib0036","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtos.2024.01.009","article-title":"Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study","volume":"32","author":"Guo","year":"2024","journal-title":"Ocul Surf"},{"issue":"15","key":"10.1016\/j.ajo.2026.06.031_bib0037","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.3390\/jcm11154632","article-title":"Association of meibomian gland dysfunction with oral statin use","volume":"11","author":"Park","year":"2022","journal-title":"J Clin Med"},{"issue":"20","key":"10.1016\/j.ajo.2026.06.031_bib0038","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.3390\/jcm12206535","article-title":"Individuals with diabetes mellitus have a dry eye phenotype driven by low symptom burden and anatomic abnormalities","volume":"12","author":"Locatelli","year":"2023","journal-title":"J Clin Med"},{"issue":"11, suppl","key":"10.1016\/j.ajo.2026.06.031_bib0039","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.031_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271267","article-title":"Identified risk factors for dry eye syndrome: a systematic review and meta-analysis","volume":"17","author":"Qian","year":"2022","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.031_bib0041","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","article-title":"The core mechanism of dry eye disease is inflammation","volume":"40","author":"Wei","year":"2014","journal-title":"Eye Contact Lens"},{"issue":"12","key":"10.1016\/j.ajo.2026.06.031_bib0042","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.031_bib0043","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archopht.1984.01040030851031","article-title":"Conjunctival goblet cell densities in ocular surface disease","volume":"102","author":"Nelson","year":"1984","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.031_bib0044","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1167\/iovs.07-0069","article-title":"Dry eye\u2013induced conjunctival epithelial squamous metaplasia is modulated by interferon-\u03b3","volume":"48","author":"De Paiva","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.031_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13075-015-0582-9","article-title":"Altered balance of interleukin-13\/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sj\u00f6gren\u2019s syndrome","volume":"17","author":"Bian","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajo.2026.06.031_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.10.008","article-title":"Complexity of the tear film: importance in homeostasis and dysfunction during disease","volume":"117","author":"Dartt","year":"2013","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.031_bib0047","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.031_bib0048","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/02713680902972366","article-title":"The effect of meibomian lipids and tear proteins on evaporation rate under controlled in vitro conditions","volume":"34","author":"Herok","year":"2009","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.031_bib0049","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.031_bib0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/01658107.2020.1755872","article-title":"Statins in neuro-ophthalmology","volume":"45","author":"Tan","year":"2021","journal-title":"Neuro-Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.031_bib0051","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4239\/wjd.v6.i2.352","article-title":"Statin use and risk of diabetes mellitus","volume":"6","author":"Chogtu","year":"2015","journal-title":"World J Diabetes"},{"issue":"11","key":"10.1016\/j.ajo.2026.06.031_bib0052","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s10792-019-01110-y","article-title":"Diabetes mellitus is associated with dry eye syndrome: a meta-analysis","volume":"39","author":"Yoo","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.031_bib0053","article-title":"Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics","volume":"2016","author":"Zhang","year":"2016","journal-title":"J Ophthalmol"},{"issue":"9716","key":"10.1016\/j.ajo.2026.06.031_bib0054","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.031_bib0055","article-title":"Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics","volume":"2016","author":"Zhang","year":"2016","journal-title":"J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.031_bib0056","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jep.12462","article-title":"Statin prescribing according to gender, age and indication: what about the benefit\u2013risk balance?","volume":"22","author":"Wallach-Kildemoes","year":"2016","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.ajo.2026.06.031_bib0057","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.atherosclerosis.2018.11.015","article-title":"Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004\u20132015","volume":"280","author":"Blais","year":"2019","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.031_bib0058","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.exger.2012.03.020","article-title":"Aging and dry eye disease","volume":"47","author":"Ding","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.ajo.2026.06.031_bib0059","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","article-title":"TFOS DEWS III: diagnostic methodology","volume":"279","author":"Wolffsohn","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.031_bib0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtos.2022.06.004","article-title":"Impact of aging on the pathophysiology of dry eye disease: a systematic review and meta-analysis","volume":"25","author":"Kitazawa","year":"2022","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.031_bib0061","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/13697137.2020.1849087","article-title":"Dry eye disease symptoms and quality of life in perimenopausal and postmenopausal women","volume":"24","author":"Garcia-Alfaro","year":"2021","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.031_bib0062","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0021-9150(00)00397-X","article-title":"Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins","volume":"153","author":"Rauch","year":"2000","journal-title":"Atherosclerosis"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:33:27Z","timestamp":1788280407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426003430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"alternative-id":["S0002939426003430"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.031","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Statin Use and Dry Eye Disease: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}